C Bernigaud, D Guillemot, A Ahmed-Belkacem, L Grimaldi-Bensouda, A Lespine, F Berry, L Softic, C Chenost, G Do-Pham, B Giraudeau, S Fourati, O Chosidow, Ap-Hp Dermatologie
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
{ 'indexed': {'date-parts': [[2022, 4, 3]], 'date-time': '2022-04-03T12:39:43Z', 'timestamp': 1648989583678},
'reference-count': 0,
'publisher': 'Elsevier BV',
'issue': '12',
'license': [ { 'start': { 'date-parts': [[2020, 12, 1]],
'date-time': '2020-12-01T00:00:00Z',
'timestamp': 1606780800000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': { 'domain': ['clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 12]]},
'DOI': '10.1016/j.annder.2020.09.231',
'type': 'journal-article',
'created': { 'date-parts': [[2020, 11, 25]],
'date-time': '2020-11-25T23:01:55Z',
'timestamp': 1606345315000},
'page': 'A194',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 1,
'title': 'Bénéfice de l’ivermectine\xa0: de la gale à la COVID-19, un exemple de sérendipité',
'prefix': '10.1016',
'volume': '147',
'author': [ {'given': 'C.', 'family': 'Bernigaud', 'sequence': 'first', 'affiliation': []},
{'given': 'D.', 'family': 'Guillemot', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.', 'family': 'Ahmed-Belkacem', 'sequence': 'additional', 'affiliation': []},
{'given': 'L.', 'family': 'Grimaldi-Bensouda', 'sequence': 'additional', 'affiliation': []},
{'given': 'A.', 'family': 'Lespine', 'sequence': 'additional', 'affiliation': []},
{'given': 'F.', 'family': 'Berry', 'sequence': 'additional', 'affiliation': []},
{'given': 'L.', 'family': 'Softic', 'sequence': 'additional', 'affiliation': []},
{'given': 'C.', 'family': 'Chenost', 'sequence': 'additional', 'affiliation': []},
{'given': 'G.', 'family': 'Do-Pham', 'sequence': 'additional', 'affiliation': []},
{'given': 'B.', 'family': 'Giraudeau', 'sequence': 'additional', 'affiliation': []},
{'given': 'S.', 'family': 'Fourati', 'sequence': 'additional', 'affiliation': []},
{'given': 'O.', 'family': 'Chosidow', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'container-title': 'Annales de Dermatologie et de Vénéréologie',
'original-title': [],
'language': 'fr',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S015196382030627X?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S015196382030627X?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2020, 11, 26]],
'date-time': '2020-11-26T02:07:37Z',
'timestamp': 1606356457000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S015196382030627X'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 12]]},
'references-count': 0,
'journal-issue': {'issue': '12', 'published-print': {'date-parts': [[2020, 12]]}},
'alternative-id': ['S015196382030627X'],
'URL': 'http://dx.doi.org/10.1016/j.annder.2020.09.231',
'relation': {},
'ISSN': ['0151-9638'],
'subject': ['Dermatology'],
'container-title-short': 'Annales de Dermatologie et de Vénéréologie',
'published': {'date-parts': [[2020, 12]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Bénéfice de l’ivermectine\xa0: de la gale à la COVID-19, un exemple de '
'sérendipité',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'Annales de Dermatologie et de Vénéréologie',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.annder.2020.09.231',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'simple-article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': 'Copyright © 2020 Published by Elsevier Masson SAS',
'name': 'copyright',
'label': 'Copyright'}]}
